A simple, highly sensitive, precise and accurate high-performance liquid chromatographic (HPLC) method was developed and validated for the determination of teneligliptin in rabbit plasma samples. The chromatographic separation was achieved with a reverse phase column thermo C18 (4.6×100 mm, 5µ) and the mobile phase consisted of methanol and 5mm potassium phosphate buffer (60:40 v/v) at a flow rate of 1mL/min. Sitagliptin was used as an internal standard. The retention time of Teneligliptin and sitagliptin were found to be 3.9 and 2.2min respectively. The calibration curve was linear (r2 > or = 0.99) ranging from 7.20 to 470ng/ml and the lower limit of quantification was 7.20 ng/mL. Interday precision were lower than 5% (CV) and accuracy ranged from 90 to 110% in terms of percent accuracy. Mean extraction recovery was found to be above 82%. The method was successfully developed and validated in rabbit plasma for excellent selectivity, accuracy, precision, recovery and stability.
INTRODUCTION
Teneligliptin has the molecular formula C 22 H 30 N 6 
Pharmacokinetics
After oral administration of a single 20 mg and 40 mg dose to healthy subjects, teneligliptin was rapidly absorbed, with peak plasma concentrations (mean T max) occurring at 1.8 hours and 1 hour post dose. Plasma AUC of teneligliptin increased in a dose-proportional manner.
Following a single oral 20 mg and 40 mg dose to healthy volunteers, mean plasma AUC of teneligliptin was 2028.9 and 3705.1 ng*hr/ml, Cmax was 187.2 and 382.4 ng/ml and apparent terminal halflife (t1/2) was 24.2 and 20.8 hours. Plasma AUC of teneligliptin increased following 20 mg doses at steady-state compared to the first dose. Coadministration with food reduces the Cmax by 20%, increases the Tmax from 1.1 to 2.6 hours but does not affect the AUC of teneligliptin as compared to that in the fasting state. total score 7-9) was approximately 1.25 times and 1.38 times that of healthy adult subjects, respectively. Compared to healthy adult subjects, the AUC0-∞ of subjects with mild and moderate hepatic impairments was approximately 1.46 times and 1.59 times higher than that of healthy adult subjects, respectively. There have been no previous clinical studies using teneligliptin in patients with severe hepatic impairment (Child-Pugh classification: total score was greater than 9).
Adverse effects
The most common adverse reactions reported with teneligliptin are hypoglycemia and 
Warnings and Precautions
Teneligliptin Solubility: in water, DMSO, methanol.
PKa: 8.7. 
Chromatographic conditions
Chromatographic separations were achieved by using Thermo C18 column (250×4. 
Accuracy and precision
Intra-day accuracy and precision were determined by duplicate analysis of six sets of samples spiked with four different concentrations of teneligliptin at low, medium, high quality control samples (18.000,211.680,376.000ng/mL) including LLOQ (7.200 ng/mL) within a day or on 6 consecutive days. For acceptance criteria for intra and inter-day precision, accuracy should be within 85-115% of the nominal concentration and coefficient of variation (%CV) values should be <15% over the calibration range, except at the LLOQ, where accuracy should be between 80 -120% and %CV should not be more than 20%. (table-2) .
Selectivity
The selectivity of the assay methodology was established using a minimum of six independent sources of the same matrix. There were no interferences from the endogenous material at the retention time for both teneligliptin and internal standard (sitagliptin). The representative chromatogram is shown in Figure 3 .
Recovery
Recovery of teneligliptin was evaluated by comparing the mean peak areas of three extracted low, medium and high quality control samples to mean peak areas of three neat reference solutions (un-extracted). Recovery of internal standard was evaluated at a concentration of 210 ng/mL and corresponding mean peak area of the extracted samples compared to the mean peak areas of neat reference solutions. Recovery of the analyte need not be 100%, but the extent of recovery for analyte (teneligliptin) and internal standard (sitagliptin) should be consistent and reproducible.
www.wjpr.net
Vol 6, Issue 10, 2017. 596
Nallakumar et al.
World Journal of Pharmaceutical Research Stability
In order to find out the stability of teneligliptin in rabbit plasma, bench top stability, freeze thaw stability and long term stability studies were carried out by using six replicates of the low and high plasma quality control samples. For the bench top stability, frozen plasma samples were kept at room temperature for 24 hr before sample preparation. Freeze-thaw stability of the samples was obtained over three freeze-thaw cycles, by thawing at room temperature for 2-3 hr and refrozen for 12-24 hr for each cycle. Freshly prepared solutions are taken and analysed after 24hours and Long term stability of teneligliptin in rabbit plasma was tested after 3 days. For the acceptance criteria of stability, the deviation compared to the freshly prepared standard should be within ± 15% of the nominal concentration.
Matrix effect
The matrix effect was performed in 6 different lots of rabbit plasma by taking aqueous samples and spiked plasma samples at HQC and LQC level (6replicates of each). Matrix suppression or enhancement was calculated as follows: 100×mean peak area of post extracted sample/mean peak area of neat standard solution. The acceptance criteria for matrix effect implied that the %CV should be less than 15% of matrices tested and at least 80% of matrices should meet the above criteria. the results obtained were displayed in Table 4 . 
DISCUSSION

RP-HPLC optimization
The RP-HPLC method for the detection of Teneligliptin in rabbit plasma was investigated.
Teneligliptin was dissolved in methanol to obtain the primary stock solution followed by subsequent dilution in methanol: water (80:20) and was directly introduced into the HPLC and various conditions are maintained and checked out for the response.
During the early stages of method development, attempts were made to optimize the response in a perfect manner. And. When standard working stock solutions of the analyte were directly injected into the HPLC system, it was observed that the response for the analyte was linear over the mentioned calibrated range. The linearity was found to be best it for the calibration range when the compound was dissolved in methanol: water .20-490 ng/mL. This method had a quantification limit of 7.20 ng/mL, which was adequate enough to quantify the drug in rabbit plasma.
CONCLUSION
Since merits of HPLC compare to other techniques are well recognized, a highly sensitive, specific, less cost compared to LCMS/MS and reproducible HPLC method is more valuable.
In addition, along with method development, the method is also validated to quantify the concentration range of 7.20 -470 ng/mL of Teneligliptin in rabbit plasma samples. The HPLC method presented here fulfils the criteria generally required for the Bioanalytical assays. This Bioanalytical method has sensitivity, selectivity and recovery above 85%.
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